Literature DB >> 12673033

Brain and heart specific alteration of methamphetamine (MAP) distribution in MAP-sensitized rat.

Naoto Nakagawa1, Takanori Hishinuma, Hitoshi Nakamura, Toru Yamazaki, Hiroki Tsukamoto, Masahiro Hiratsuka, Tatsuo Ido, Michinao Mizugaki, Tetsuya Terasaki, Junichi Goto.   

Abstract

The repeated administration of methamphetamine (MAP) causes behavioral sensitization in animals. We previously reported that the high accumulation of MAP was observed in the MAP-sensitized animal brain, which suggested that this phenomenon is an important factor in the development or expression of behavioral sensitization. The purpose of the present study is to elucidate the MAP distribution in the MAP-sensitized rat using gas chromatography/mass spectrometry (GC/MS). As a result, the MAP distribution in the heart at 10 min when showing a high accumulation of MAP in the MAP-sensitized rat brain was significantly higher than that of the control rat, whereas no significant differences in the liver, kidney, abdominal muscle, femoral muscle and blood were observed. In the brain and heart, there was no different distribution at 1 min, reflecting only the influx process from blood to brain and heart. On the contrary, there was the significant difference at 10 min, reflecting both the influx and efflux process, suggesting that the efflux process of MAP from brain or heart to blood may be slow due to MAP sensitization. In conclusion, it was clear that the brain and heart specific alteration of the MAP distribution occurred in the MAP sensitization. It was considered that the high accumulation of MAP in the MAP-sensitized rat brain may be related to the expression of behavioral sensitization and that the delayed efflux of MAP in the MAP-sensitized rat heart may be connected with the cardiac toxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673033     DOI: 10.1248/bpb.26.506

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

1.  Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone.

Authors:  Chi-Tso Chiu; Tangeng Ma; Ing K Ho
Journal:  Brain Res Bull       Date:  2005-09-30       Impact factor: 4.077

2.  Cannabidiol attenuates methamphetamine-induced cardiac inflammatory response through the PKA/CREB pathway in rats.

Authors:  Qianyun Nie; Wenjuan Dong; Baoyu Shen; Genmeng Yang; Hao Yu; Ruilin Zhang; Yanxia Peng; Yang Yu; Shijun Hong; Lihua Li
Journal:  Ann Transl Med       Date:  2022-09

3.  Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function.

Authors:  Chowdhury S Abdullah; Richa Aishwarya; Shafiul Alam; Mahboob Morshed; Naznin Sultana Remex; Sadia Nitu; Gopi K Kolluru; James Traylor; Sumitra Miriyala; Manikandan Panchatcharam; Brandon Hartman; Judy King; Mohammad Alfrad Nobel Bhuiyan; Sunitha Chandran; Matthew D Woolard; Xiuping Yu; Nicholas E Goeders; Paari Dominic; Connie L Arnold; Karen Stokes; Christopher G Kevil; A Wayne Orr; Md Shenuarin Bhuiyan
Journal:  Commun Biol       Date:  2020-11-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.